EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases 27.03.2023 / 16:04 CET/CESTThe issuer is solely responsible for the content of this announcement. Secarna Pharmaceuti...